Half of all women experience a false positive mammogram after 10 years of annual breast cancer screening with 3D mammography, a UC Davis-led study estimates. This risk was lower for women who had mammograms every other year. 3D screening showed slightly lower false positive results than standard mammography.
In a first of its kind clinical trial led by UC Davis Health, HOPE-2 showed that cellular therapy is safe and effective in stopping the deterioration of upper limb and heart functions in patients with late-stage Duchenne muscular dystrophy.
The UC Davis MIND Institute’s Leadership Education in Neurodevelopmental and Related Disabilities program is recruiting. Self-advocates, family members, researchers and clinicians who are passionate about improving the lives of people with autism and other neurodevelopmental disabilities are invited to apply.
The UC Davis MIND Institute has received funding from the Patient-Centered Outcomes Research Institute to create community partnerships to increase equity in research. The goal is to create a network that includes individuals with intellectual and developmental disabilities from diverse communities.
Researchers at the UC Davis MIND Institute have identified a gene linked to fetal brain development and autism. Their work shows that the gene is influenced by the mother’s early prenatal vitamins use and placental oxygen levels.
A long-term study by UC Davis MIND Institute researchers finds significant changes in brain development linked to anxiety in autistic children. The study, which included brain scans and interviews, also provides new evidence that supports forms of anxiety specific to autism.
A new UC Davis Health study found that taking bile acids or treatments that regulate their production may help control inflammation caused by psoriasis, a chronic skin condition.
The MIND Institute’s RISE-UP program is recruiting undergraduate students for its summer program. The unique opportunity is focused on students interested in serving historically underserved communities. They’ll learn more about research, clinical care, community support, neurodevelopmental disabilities and social justice.
A study led by UC Davis has found significant gut bacteria profile differences between Black and white women, even after accounting for their insulin sensitivity status.
A new study by researchers with the UC Davis Comprehensive Cancer Center shows Latino smokers on Medi-Cal are still not getting the cessation information they need to help them get treatment for tobacco addiction.
The UC Davis Health Cancer Care Network is adding Marshall Medical Center as its newest member. The cancer services affiliation allows Marshall patients in El Dorado County access to the renowned UC Davis Comprehensive Cancer Center to ensure they have the latest diagnostic and treatment options.
The associate director for the clinical research program at UC Davis Comprehensive Cancer Center embarks on new leadership role in early 2022 as CEO of the International Association for the Study of Lung Cancer
The UC Davis Comprehensive Cancer Center director has appointed a new medical director to lead the nationally recognized Thoracic Oncology Program. Jonathan Wesley Riess replaces David. R. Gandara who will co-direct a new center in experimental cancer therapeutics.
UC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease, an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation.
Orin Bloch is the new co-leader of UC Davis Comprehensive Cancer Center Biomedical Technology Program, which works to further innovative advances in cancer research, diagnosis, and therapy. His appointment is effective Dec. 1, 2021.
A UC Davis Health team has developed a new positron emission tomography (PET) scan imaging-based tool to detect liver inflammation in patients affected with non-alcoholic fatty liver disease. The condition affects nearly a third of the population of the United States.
A new article published in The New England Journal of Medicine suggests that secondary antibodies known as “anti-idiotype antibodies” could be responsible for some of the side effects of COVID-19 vaccines and the symptoms of long-haul COVID.
A new UC Davis MIND Institute study suggests that parent-led language testing delivered via telehealth is effective for children with autism. The format was tested in both English and Spanish-speaking families and may provide a new way to measure the efficacy of treatments.
UC Davis Health scientists developed a new tool to translate cardiac studies from animal models to humans. The tool will help in better understanding arrhythmia and other heart conditions and support the search for effective cardiac therapies.
New study results show compliance with smoke- and tobacco-free policies on college campuses could be more effective with the rollout of a Tobacco Tracker that can also influence behavior and attitudes.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right